Based on reducing airway hyperresponsiveness of children with asthma, observing the clinical effect of adding and subtracting Xingfu Liujunzi Decoction on chronic duratio
Phase 1
- Conditions
- asthma
- Registration Number
- ITMCTR2000004011
- Lead Sponsor
- Yueyang Hospital of Integraced Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) It conforms to the diagnostic criteria of clinical chronic duration of asthma in western medicine.
(2) Between the ages of 5 and 14 years.
(3) Immunomodulatory drugs not used in Traditional Chinese and western medicine in the previous month were included.
(4) The legal guardian of the child agrees to participate in this study and signs the informed consent.
Exclusion Criteria
(1) Patients with heart, liver, kidney, hematopoietic system and other serious primary diseases and psychosis.
(2) Those with other lesions that, according to the judgment of the researchers, reduce the possibility of inclusion or complicate inclusion.
(3) Those who are participating in clinical trials of other drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Control level;
- Secondary Outcome Measures
Name Time Method ung function;